The Relationship Between Pediatric Combination Vaccines and Market Effects.

• Autores: Banafsheh Behzad, Sheldon H. Jacobson, Janet A. Jokela, Edward C. Sewell
• Localización: American journal of public health, ISSN 0090-0036, Vol. 104, Nº. 6, 2014, págs. 998-1004
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • We explored market factors that affect pediatric combination vaccine uptake in the US public-sector pediatric vaccine market. We specifically examined how Pediarix and Pentacel earned a place in the 2009-2012 lowest overall cost formulary. Direct competition between Pediarix and Pentacel is driven by the indirect presence of the Merck Haemophilus influenzae type b vaccine and the Recommended Childhood Immunization Schedule requirement for a hepatitis B birth dose. The resulting analysis suggests that Pentacel would never have earned a place in the lowest overall cost formulary for 2009-2012 federal contract prices for any cost of an injection unless the Merck H influenzae type b advantage was ignored and the hepatitis B birth dose administration cost was recognized by health care providers in designing the lowest overall cost formularies. [ABSTRACT FROM AUTHOR]